RG
TOI icon

Redmile Group’s The Oncology Institute TOI Stock Holding History

Redmile Group’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-318,082
Closed -$216K – 79
2023
Q1 		$216K Sell
318,082
-1,265,076
-80% -$1.61M 0.01% 76
2022
Q4 		$2.61M Hold
1,583,158
– – 0.11% 59
2022
Q3 		$7.33M Sell
1,583,158
-152,958
-9% -$899K 0.28% 54
2022
Q2 		$8.79M Sell
1,736,116
-678,316
-28% -$4.94M 0.34% 52
2022
Q1 		$17.2M Sell
2,414,432
-85,568
-3% -$577K 0.54% 46
2021
Q4 		$24.4M Buy
+2,500,000
New +$22.2M 0.55% 43

Other funds holding TOI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group's TOI Position: Q2 2023 in Review

Redmile Group sold out of The Oncology Institute (TOI) in Q2 2023, closing a stake of 318,082 shares — an estimated $216K sold.

Redmile Group first reported a position in TOI in Q4 2021 and held it in 6 quarters. The position peaked at $24.4M in Q4 2021. 38 funds tracked by Wall St. Rank hold TOI as of Q2 2023.

  • Redmile Group reported no remaining The Oncology Institute position as of Q2 2023 after selling out during the quarter.
  • Redmile Group sold 318,082 The Oncology Institute shares in Q2 2023, an estimated $216K.
  • Redmile Group first reported a position in The Oncology Institute in Q4 2021 and held it in 6 quarters.
  • Redmile Group's The Oncology Institute position peaked at $24.4M in Q4 2021.
  • 38 funds tracked by Wall St. Rank held The Oncology Institute as of Q2 2023.

Based on Redmile Group's 13F filing for Q2 2023, filed 14 Aug 2023.